🇺🇸 D5NS in United States

23 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 28 March 2025 – 28 March 2026
• Total reports: 23

Most-reported reactions

1. Chest Pain — 3 reports (13.04%)
2. Dehydration — 3 reports (13.04%)
3. Vomiting — 3 reports (13.04%)
4. Asthenia — 2 reports (8.7%)
5. Back Pain — 2 reports (8.7%)
6. Blood Glucose Increased — 2 reports (8.7%)
7. Cough — 2 reports (8.7%)
8. Drug Ineffective — 2 reports (8.7%)
9. Dyspnoea — 2 reports (8.7%)
10. Grunting — 2 reports (8.7%)

Source database →

Frequently asked questions

Is D5NS approved in United States?

D5NS does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for D5NS in United States?

MemorialCare is the originator. The local marketing authorisation holder may differ — check the official source linked above.